Draft:Gabriel Otte
American researcher
From Wikipedia, the free encyclopedia
Gabriel Otte is an American entrepreneur, software engineer, and researcher.[1][2] He is the co-founder of the biotechnology company Freenome and the fintech firm Dinari, and is a partner at Healthcare Co-op.[3][4][5]
 | Review waiting, please be patient.
This may take 8 weeks or more, since drafts are reviewed in no specific order. There are 3,445 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
Submission declined on 25 September 2025 by Gheus (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
This draft has been resubmitted and is currently awaiting re-review. |  |
- Freenome and Dinari (Co-founder)
- Healthcare Co-op (Partner)
Gabriel Otte | |
|---|---|
| Born | United States |
| Education | University of Balamand (Master of Theology), Cornell University (B.A. in Chemistry and Chemical Biology) |
| Occupations | Entrepreneur, software engineer, researcher |
| Known for |
|
Early life and education
Otte graduated from Cornell University with a B.A. in Chemistry and Computational Biology in 2011.[6] During and after his undergraduate years, he worked as a research assistant at Cornell, contributing to biomedical research linking small blood vessel diseases to Alzheimer’s disease.[7]
He later earned a Master of Theology through the Antiochian House of Studies in conjunction with the University of Balamand in Lebanon.[8]
Career
Otte began his career by joining Apple as a software engineer.[3] He also worked as a software engineer at Glyde Corporation.[9]
In 2014, Otte co-founded Freenome, a biotech company that applies machine learning and genomics for early cancer detection through blood-based diagnostic tests.[10][11][12][13] He served as CEO of the company from 2016 until 2021.[14][15]
While at Freenome, Otte also became a Partner at Healthcare Co-op in May 2018, and he continues to be actively involved in that role.[16]
After his time at Freenome, he shifted his focus to the blockchain and finance sectors. He co-founded Dinari, a startup designed to tokenize real-world assets, including U.S. equities, with the goal of making stock trading more accessible and decentralized.[17] Under his co-leadership, Dinari secured substantial funding and worked toward regulatory compliance, including registering as a transfer agent with the United States Securities and Exchange Commission to support tokenized stock trading.[18][19][20]
Otte was featured in Forbes 30 Under 30 in 2017.[21]
Selected publications
Some of Otte's selected publications include:
- Wan, Nathan; Weinberg, David; Liu, Tzu-Yu; Niehaus, Katherine; Otte, Gabriel L.; Delubac, Daniel; Kannan, Ajay; White, Brandon; Bailey, Mitch; Bertin, Marvin; Boley, Nathan; Bowen, Derek; Cregg, James; Drake, Adam M.; Ennis, Riley (2019-08-23). "Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA". BMC Cancer. 19 (1): 832. doi:10.1186/s12885-019-6003-8. ISSN 1471-2407. PMC 6708173. PMID 31443703.
- Nelson, David M.; Jaber-Hijazi, Farah; Cole, John J.; Robertson, Neil A.; Pawlikowski, Jeffrey S.; Norris, Kevin T.; L. Otte, Gabriel (2016-07-25). "Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability". Genome Biology. 17 (34) 158. doi:10.1186/s13059-016-1017-x. ISSN 1474-760X. PMC 4967351. PMID 27455871.
- Butin-Israeli, Veronika; Adam, Stephen A.; Jain, Nikhil; Otte, Gabriel L.; Neems, Daniel; Wiesmüller, Lisa; Berger, Shelly L.; Goldman, Robert D. (2015-03-05). "Role of lamin B1 in chromatin instability". Molecular and Cellular Biology. 35 (5): 884–898. doi:10.1128/MCB.01145-14. ISSN 0270-7306. PMC 4323489. PMID 25535332.
Philanthropy
In 2017, Otte and his wife established the Otte Family Capital foundation, which supports initiatives in healthcare, technology, and faith-based programs.[14] He is also an ordained deacon at St. Stephen Orthodox Church in Campbell, California, under the Antiochian Orthodox Christian Archdiocese of North America.[14]
- provide significant coverage: discuss the person in detail, not brief mentions or interviews lacking independent analysis;
- are reliable: from reputable outlets with editorial oversight;
- are independent: not connected to the person, such as interviews, press releases, the subject's own website, or sponsored content.
Please add references that meet all three of these criteria. If none exist, the subject is not yet suitable for Wikipedia.